Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resectable Non-Small Cell Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT03916627
What this trial is testing

Neoadjuvant Cemiplimab for the Treatment of Resectable NSCLC, HCC, and HNSCC in Adult Patients

Who this might be right for
Non-small Cell Lung CancerHepatocellular CarcinomaHead and Neck Squamous Cell Carcinoma
Regeneron Pharmaceuticals 65
Testing effectiveness (Phase 2)Looking for participantsNCT06951464
What this trial is testing

BL-B01D1 and Almonertinib in Patients With Resectable EGFR+ Stage II-IIIB NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Sichuan University 40
Testing effectiveness (Phase 2)WithdrawnNCT02607423
What this trial is testing

Fludeoxyglucose F-18 PET/CT in Predicting Response to Chemotherapy in Patients With Stage IIIA Non-small Cell Lung Cancer That Can Be Removed by Surgery

Who this might be right for
Stage IIIA Non-Small Cell Lung Cancer
ECOG-ACRIN Cancer Research Group
Testing effectiveness (Phase 2)Ended earlyNCT03366766
What this trial is testing

Nivolumab Plus Cisplatin/Pemetrexed or Cisplatin/Gemcitabine as Induction in Resectable Non-Small Cell Lung Cancer

Who this might be right for
Non-Squamous Non-Small Cell Lung CarcinomaStage I Non-Small Cell Lung CancerStage IA Non-Small Cell Lung Carcinoma+5 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 14
Large-scale testing (Phase 3)Looking for participantsNCT07554846
What this trial is testing

Comparison of Perioperative Immunotherapy, Adjuvant Immunotherapy or Neoadjuvant Immunotherapy for Resectable Stage II-IIIA NSCLC

Who this might be right for
Resectable Stage II-IIIa NSCLC
Fudan University 759
Testing effectiveness (Phase 2)Looking for participantsNCT05469022
What this trial is testing

Neoadjuvant Lazertinib Therapy in EGFR-Mutation Positive Lung Adenocarcinoma Detected by BALF Liquid Biopsy

Who this might be right for
Non Small Cell Lung Cancer
Konkuk University Medical Center 40
Early research (Phase 1)Ended earlyNCT01159964
What this trial is testing

Evaluation of a New Anti-cancer Vaccine for Patients With Non-small Cell Lung Cancer, After Tumor Removal by Surgery

Who this might be right for
Lung Cancer, Non-Small Cell
GlaxoSmithKline 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06688656
What this trial is testing

Neoadjuvant Chemotherapy Sequentially Combined with Sintilimab in Resectable EGFR-Mutant NSCLC

Who this might be right for
Lung Cancer
Shanghai Chest Hospital 30
Testing effectiveness (Phase 2)Ended earlyNCT04832854
What this trial is testing

A Study Evaluating the Safety and Efficacy of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab, With or Without Platinum-Based Chemotherapy, in Participants With Previously Untreated Locally Advanced Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)
Hoffmann-La Roche 50
Testing effectiveness (Phase 2)Looking for participantsNCT07630168
What this trial is testing

Effects of Infusion Timing on Treatment Response in Solid Tumors

Who this might be right for
Lung CancerNon-small Cell Lung CancerMetastatic Lung Cancer+4 more
UNC Lineberger Comprehensive Cancer Center 238
Early research (Phase 1)Ended earlyNCT01373463
What this trial is testing

Cisplatin and Pemetrexed With Radiation Followed by Lobectomy

Who this might be right for
Nonsquamous Nonsmall Cell Neoplasm of LungNonsmall Cell Lung Cancer Stage III
Medical University of South Carolina 48
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06585644
What this trial is testing

A Clinical Trial of Furmonertinib Combination Therapy As Neoadjuvant Treatment in Resectable EGFR-Mutated NSCLC

Who this might be right for
Lung Cancer (NSCLC)
Shanghai Pulmonary Hospital, Shanghai, China 44
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07771764
What this trial is testing

Exploratory Clinical Study of Iruplaltinib Combined With Pemetrexed as Neoadjuvant Therapy for Resectable ALK-Positive Non-Squamous Non-Small Cell Lung Cancer

Who this might be right for
ALK-positive Non Small Cell Lung Cancer
First Affiliated Hospital of Fujian Medical University 30
Post-approval studies (Phase 4)UnknownNCT05387109
What this trial is testing

Penpulimab Combined With Anlotinib in Neoadjuvant Treatment of Resectable Non-small Cell Lung Cancer

Who this might be right for
NSCLC
Tang-Du Hospital 41
Large-scale testing (Phase 3)Active Not RecruitingNCT04025879
What this trial is testing

Neoadjuvant Chemotherapy Plus Nivolumab Versus Neoadjuvant Chemotherapy Plus Placebo, Followed by Surgical Removal and Adjuvant Treatment With Nivolumab or Placebo for Participants With Surgically Removable Early Stage Non-small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Bristol-Myers Squibb 461
Large-scale testing (Phase 3)UnknownNCT06020352
What this trial is testing

The Efficacy and Safety of KN046 Combined With Axitinib

Who this might be right for
NSCLC
Shanghai Pulmonary Hospital, Shanghai, China 20
Testing effectiveness (Phase 2)Looking for participantsNCT04875585
What this trial is testing

Trial Exploring Combined Neoadjuvant Therapy With Pembrolizumab/Lenvatinib + Adjuvant Pembrolizumab in Pat. With NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Medical University Innsbruck 33
Not applicableStudy completedNCT03613467
What this trial is testing

Is Video-assisted Thoracoscopic Lobectomy a Clinical Alternative for Surgically Resectable Pathologic N2 NSCLC Patients

Who this might be right for
Non-small Cell Lung Cancer
Tang-Du Hospital 2,145
Testing effectiveness (Phase 2)UnknownNCT05170581
What this trial is testing

Clinical Study of Sintilimab Combined With Chemotherapy in Neoadjuvant Treatment of Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
The Second Affiliated Hospital of Shandong First Medical University 30
Testing effectiveness (Phase 2)Study completedNCT02804776
What this trial is testing

PRe-Operative Gefitinib in Resectable EGFR Mutation Positive Lung Cancer With Sector Sequencing for Biomarker Discovery

Who this might be right for
Non-small Cell Lung Cancer
National Cancer Centre, Singapore 15
Next Page